C4 Therapeutics, Inc. (CCCC)
NASDAQ: CCCC · Real-Time Price · USD
2.380
+0.150 (6.73%)
At close: Jul 14, 2025, 4:00 PM
2.360
-0.020 (-0.84%)
After-hours: Jul 14, 2025, 7:24 PM EDT
C4 Therapeutics Market Cap
C4 Therapeutics has a market cap or net worth of $169.00 million as of July 14, 2025. Its market cap has decreased by -47.85% in one year.
Market Cap
169.00M
Enterprise Value
-13.41M
1-Year Change
-47.85%
Ranking
Category
Stock Price
$2.38
Market Cap Chart
Since the IPO on October 2, 2020, C4 Therapeutics's market cap has decreased from $772.72M to $169.00M, a decrease of -78.13%. That is a compound annual growth rate of -27.26%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 11, 2025 | 158.35M | -37.69% |
| Dec 31, 2024 | 254.12M | -8.73% |
| Dec 29, 2023 | 278.44M | -3.60% |
| Dec 30, 2022 | 288.85M | -81.55% |
| Dec 31, 2021 | 1.57B | 9.83% |
| Dec 31, 2020 | 1.43B | 84.49% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 711.91B |
| Johnson & Johnson | 377.51B |
| AbbVie | 339.94B |
| Novo Nordisk | 305.41B |
| UnitedHealth Group | 275.86B |
| Novartis AG | 236.71B |
| Abbott Laboratories | 229.69B |
| AstraZeneca | 218.74B |